| Initial Evaluation of [18F]DCFPyL for Prostate-Specific Membrane Antigen (PSMA)-Targeted PET Imaging of Prostate Cancer Z Szabo, E Mena, SP Rowe, D Plyku, R Nidal, MA Eisenberger, ... Molecular imaging and biology 17, 565-574, 2015 | 514 | 2015 |
| 2-(3-{1-Carboxy-5-[(6-[18F]Fluoro-Pyridine-3-Carbonyl)-Amino]-Pentyl}-Ureido)-Pentanedioic Acid, [18F]DCFPyL, a PSMA-Based PET Imaging Agent for Prostate … Y Chen, M Pullambhatla, CA Foss, Y Byun, S Nimmagadda, ... Clinical cancer research 17 (24), 7645-7653, 2011 | 440 | 2011 |
| Radiolabeled small-molecule ligands for prostate-specific membrane antigen: in vivo imaging in experimental models of prostate cancer CA Foss, RC Mease, H Fan, Y Wang, HT Ravert, RF Dannals, ... Clinical cancer research 11 (11), 4022-4028, 2005 | 370 | 2005 |
| Biodistribution, tumor detection, and radiation dosimetry of 18F-DCFBC, a low-molecular-weight inhibitor of prostate-specific membrane antigen, in patients with metastatic … SY Cho, KL Gage, RC Mease, S Senthamizhchelvan, DP Holt, ... Journal of Nuclear Medicine 53 (12), 1883-1891, 2012 | 340 | 2012 |
| Synthesis and evaluation of technetium-99m-and rhenium-labeled inhibitors of the prostate-specific membrane antigen (PSMA) SR Banerjee, CA Foss, M Castanares, RC Mease, Y Byun, JJ Fox, ... Journal of medicinal chemistry 51 (15), 4504-4517, 2008 | 338 | 2008 |
| N-[N-[(S)-1, 3-Dicarboxypropyl] carbamoyl]-4-[18F] fluorobenzyl-L-cysteine,[18F] DCFBC: a new imaging probe for prostate cancer RC Mease, CL Dusich, CA Foss, HT Ravert, RF Dannals, J Seidel, ... Clinical Cancer Research 14 (10), 3036-3043, 2008 | 323 | 2008 |
| 68Ga-Labeled Inhibitors of Prostate-Specific Membrane Antigen (PSMA) for Imaging Prostate Cancer SR Banerjee, M Pullambhatla, Y Byun, S Nimmagadda, G Green, JJ Fox, ... Journal of medicinal chemistry 53 (14), 5333-5341, 2010 | 316 | 2010 |
| Radiohalogenated prostate-specific membrane antigen (PSMA)-based ureas as imaging agents for prostate cancer Y Chen, CA Foss, Y Byun, S Nimmagadda, M Pullambhatla, JJ Fox, ... Journal of medicinal chemistry 51 (24), 7933-7943, 2008 | 290 | 2008 |
| PSMA-Based [18F]DCFPyL PET/CT Is Superior to Conventional Imaging for Lesion Detection in Patients with Metastatic Prostate Cancer SP Rowe, KJ Macura, E Mena, AL Blackford, R Nadal, ES Antonarakis, ... Molecular imaging and biology 18, 411-419, 2016 | 276 | 2016 |
| PET imaging in prostate cancer: focus on prostate-specific membrane antigen RC Mease, CA Foss, MG Pomper Current topics in medicinal chemistry 13 (8), 951-962, 2013 | 255 | 2013 |
| Imaging Enterobacteriaceae infection in vivo with 18F-fluorodeoxysorbitol positron emission tomography EA Weinstein, AA Ordonez, VP DeMarco, AM Murawski, S Pokkali, ... Science translational medicine 6 (259), 259ra146-259ra146, 2014 | 253 | 2014 |
| Interactions between human glutamate carboxypeptidase II and urea-based inhibitors: structural characterization C Barinka, Y Byun, CL Dusich, SR Banerjee, Y Chen, M Castanares, ... Journal of medicinal chemistry 51 (24), 7737-7743, 2008 | 246 | 2008 |
| 18F-DCFBC PET/CT for PSMA-based detection and characterization of primary prostate cancer SP Rowe, KL Gage, SF Faraj, KJ Macura, TC Cornish, ... Journal of Nuclear Medicine 56 (7), 1003-1010, 2015 | 237 | 2015 |
| A low molecular weight PSMA-based fluorescent imaging agent for cancer Y Chen, S Dhara, SR Banerjee, Y Byun, M Pullambhatla, RC Mease, ... Biochemical and biophysical research communications 390 (3), 624-629, 2009 | 192 | 2009 |
| Prostate-specific membrane antigen as a target for cancer imaging and therapy AP Kiess, SR Banerjee, RC Mease, SP Rowe, A Rao, CA Foss, Y Chen, ... The quarterly journal of nuclear medicine and molecular imaging: official …, 2015 | 187 | 2015 |
| 64Cu-Labeled Inhibitors of Prostate-Specific Membrane Antigen for PET Imaging of Prostate Cancer SR Banerjee, M Pullambhatla, CA Foss, S Nimmagadda, R Ferdani, ... Journal of medicinal chemistry 57 (6), 2657-2669, 2014 | 165 | 2014 |
| Sequential SPECT and optical imaging of experimental models of prostate cancer with a dual modality inhibitor of the prostate-specific membrane antigen SR Banerjee, M Pullambhatla, Y Byun, S Nimmagadda, CA Foss, ... Angewandte Chemie (International ed. in English) 50 (39), 9167, 2011 | 160 | 2011 |
| (2S)-2-(3-(1-carboxy-5-(4-211At-astatobenzamido) pentyl) ureido)-pentanedioic acid for PSMA-targeted α-particle radiopharmaceutical therapy AP Kiess, IL Minn, G Vaidyanathan, RF Hobbs, A Josefsson, C Shen, ... Journal of Nuclear Medicine 57 (10), 1569-1575, 2016 | 142 | 2016 |
| Synthesis and biological evaluation of low molecular weight fluorescent imaging agents for the prostate-specific membrane antigen Y Chen, M Pullambhatla, SR Banerjee, Y Byun, M Stathis, C Rojas, ... Bioconjugate chemistry 23 (12), 2377-2385, 2012 | 141 | 2012 |
| Auger radiopharmaceutical therapy targeting prostate-specific membrane antigen AP Kiess, I Minn, Y Chen, R Hobbs, G Sgouros, RC Mease, ... Journal of Nuclear Medicine 56 (9), 1401-1407, 2015 | 132 | 2015 |
